Wolfgang Hanisch
Amministratore Delegato presso Hospira Adelaide Pty Ltd.
Profilo
Wolfgang Hanisch has been a Director of Progen Pharmaceuticals Ltd.
since March 27, 2009.
He has been a Managing Director and a Director of Bresagen Ltd.
since October 11, 2004.
Dr. Hanisch worked for IDEC Corporation (now Biogen IDEC), Cetus Corporation and Abbot Laboratories.
He served as Founder and Chief Executive Officer of CBIO.
Dr. Hanisch served as Chief Executive Officer of Bresagen.
He served as a Non-Executive Director of Analytica Ltd.
and Psiron Ltd.
Posizioni attive di Wolfgang Hanisch
| Società | Posizione | Inizio |
|---|---|---|
Hospira Adelaide Pty Ltd.
 Hospira Adelaide Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Hospira Adelaide Pty Ltd. engages in the provision of biotechnology and research services. It also develops cell therapy technology. It offers biopharmaceutical API products including hGH, a treatment for human growth hormone deficiency; G-CSF, which is used in the treatment of leukemia; and Interferon alpha for chronic hepatitis B and C. The company was founded in 1982 and is headquartered in Thebarton, Australia. | Amministratore Delegato | - |
Precedenti posizioni note di Wolfgang Hanisch
| Società | Posizione | Fine |
|---|---|---|
| TBG DIAGNOSTICS LIMITED | Direttore/Membro del Consiglio | 01/07/2009 |
| VIRALYTICS LTD. | Direttore/Membro del Consiglio | 10/04/2006 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
Hospira Adelaide Pty Ltd.
Hospira Adelaide Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Hospira Adelaide Pty Ltd. engages in the provision of biotechnology and research services. It also develops cell therapy technology. It offers biopharmaceutical API products including hGH, a treatment for human growth hormone deficiency; G-CSF, which is used in the treatment of leukemia; and Interferon alpha for chronic hepatitis B and C. The company was founded in 1982 and is headquartered in Thebarton, Australia. | Commercial Services |
TBG Diagnostics Ltd.
 TBG Diagnostics Ltd. Pharmaceuticals: MajorHealth Technology TBG Diagnostics Ltd. engages in the research, development, and manufacture of biopharmaceuticals. It operates through the InVitro Diagnostics segment, which involves in the research of biological drugs and the retail and wholesale of veterinary drugs. The company was founded on September 26, 1989 and is headquartered in Melbourne, Australia. | Health Technology |
- Borsa valori
- Insiders
- Wolfgang Hanisch
